How many patents does
Opko Biologics have?
patents
352
families
17
granted
69
applications
283
US
75
EP
41
JP
28
WO
21
KR
19
CN
19
RoW
149
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Opko Biologics
Top ten assignees appearing on patents
2009 - 2018
| opko biologics | 207 |
| prolor biotech | 64 |
| modigene | 15 |
| opko biolog | 2 |
| modigene inc. (us) | 1 |
| opko biologies | 1 |
2009
| modigene | 5 |
2018
| opko biologics | 40 |
| prolor biotech | 1 |
| modigene | 1 |
Opko Biologics
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| long-acting polypeptides and methods of producing and administering same | 109 | 2006 |
| long-acting coagulation factors and methods of producing same | 39 | 2009 |
| long-acting coagulation factors and methods of producing same | 31 | 2006 |
| pegylated oxm variants | 27 | 2012 |
| methods of producing long acting ctp-modified growth hormone polypeptides | 22 | 2014 |
| method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotroph… 🛈 | 20 | 2012 |
| long-acting oxyntomodulin variants and methods of producing same | 20 | 2012 |
| long-acting glp-1/glucagon receptor agonists | 20 | 2011 |
| long-acting growth hormone and methods of producing same | 19 | 2006 |
| long-acting polypeptides and methods of producing and administering same | 17 | 2006 |